Literature DB >> 1545141

Potassium channel conductance: a mechanism affecting hair growth both in vitro and in vivo.

A E Buhl1, D J Waldon, S J Conrad, M J Mulholland, K L Shull, M F Kubicek, G A Johnson, M N Brunden, K J Stefanski, R G Stehle.   

Abstract

The opening of intracellular potassium channels has been suggested as a mechanism regulating hair growth. Enhancing the flux of potassium ions is a mechanism shared by several structurally diverse antihypertensive agents including minoxidil sulfate (the active metabolite of minoxidil), pinacidil, P-1075 (a potent pinacidil analog), RP-49,356, diazoxide, cromakalim, and nicorandil. Of these drugs, minoxidil, pinacidil, and diazoxide have been reported to elicit hypertrichosis in humans. This potassium channel hypothesis was examined by testing these drugs for effects on hair growth both in vitro and in vivo. For the in vitro studies, mouse vibrissae follicles were cultured for 3 d with drug and the effects on hair growth were measured by metabolic labeling. All drugs, except diazoxide, enhanced cysteine incorporation into the hair shafts of the cultured vibrissae. Diazoxide was poorly soluble and thus was tested only at low doses. Minoxidil, P-1075, cromakalim, and RP-49,356 were also evaluated in vivo by measuring hair growth effects in balding stumptail macaque monkeys. The drugs were administered topically to defined sites on balding scalps once per day for 4-5 months and the amount of hair grown was determined by monthly measurements of shaved hair weight. Three of the drugs produced significant increases in hair weight whereas, the RP-49,356 had no effect. These studies provide correlative evidence that the opening of potassium channels is an important regulatory mechanism for hair growth. This provides the impetus for further studies on this potentially important mechanism affecting hair biology.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1545141     DOI: 10.1111/1523-1747.ep12499788

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

Review 1.  Drug discovery for alopecia: gone today, hair tomorrow.

Authors:  Zenildo Santos; Pinar Avci; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2015-02-09       Impact factor: 6.098

2.  Mutation of KCNJ8 in a patient with Cantú syndrome with unique vascular abnormalities - support for the role of K(ATP) channels in this condition.

Authors:  Catherine A Brownstein; Meghan C Towne; Lovelace J Luquette; David J Harris; Nicholas S Marinakis; Peter Meinecke; Kerstin Kutsche; Philippe M Campeau; Timothy W Yu; David M Margulies; Pankaj B Agrawal; Alan H Beggs
Journal:  Eur J Med Genet       Date:  2013-10-28       Impact factor: 2.708

3.  Enhanced in vitro hair growth at the air-liquid interface: minoxidil preserves the root sheath in cultured whisker follicles.

Authors:  D J Waldon; T T Kawabe; C A Baker; G A Johnson; A E Buhl
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

Review 4.  KATP channels and cardiovascular disease: suddenly a syndrome.

Authors:  Colin G Nichols; Gautam K Singh; Dorothy K Grange
Journal:  Circ Res       Date:  2013-03-29       Impact factor: 17.367

5.  [Androgenetic alopecia].

Authors:  R Hoffman
Journal:  Hautarzt       Date:  2004-01       Impact factor: 0.751

Review 6.  Drug-induced hair loss and hair growth. Incidence, management and avoidance.

Authors:  A Tosi; C Misciali; B M Piraccini; A M Peluso; F Bardazzi
Journal:  Drug Saf       Date:  1994-04       Impact factor: 5.606

7.  Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind Study of 119 Patients.

Authors:  Alfredo Rossi; Francesca Magri; Andrea D'Arino; Flavia Pigliacelli; Marta Muscianese; Pierpaolo Leoncini; Gemma Caro; Alessandro Federico; Maria Caterina Fortuna; Marta Carlesimo
Journal:  Dermatol Pract Concept       Date:  2020-04-20

Review 8.  Repurposing of approved cardiovascular drugs.

Authors:  Junichi Ishida; Masaaki Konishi; Nicole Ebner; Jochen Springer
Journal:  J Transl Med       Date:  2016-09-20       Impact factor: 5.531

9.  Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases.

Authors:  Min Wu; Qingxiong Yu; Qingfeng Li
Journal:  Oncotarget       Date:  2016-12-13

10.  Minoxidil may suppress androgen receptor-related functions.

Authors:  Cheng-Lung Hsu; Jai-Shin Liu; An-Chi Lin; Chih-Hsun Yang; Wen-Hung Chung; Wen-Guey Wu
Journal:  Oncotarget       Date:  2014-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.